These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29660734)

  • 21. Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia.
    Le Moli R; Endert E; Fliers E; Prummel MF; Wiersinga WM
    Neth J Med; 2003 Feb; 61(2):44-8. PubMed ID: 12735420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Perić LA
    J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperprolactinaemia and female infertility.
    Godó G
    Acta Med Hung; 1984; 41(4):185-93. PubMed ID: 6440115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!
    Gezer A; Atasü T; Hekim C; Stenman UH; Hekim N
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):206-8. PubMed ID: 15653204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
    Haddad PM; Wieck A
    Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
    Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
    Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary gonadotropin-releasing hormone (GnRH) receptor responses to GnRH in hypothalamus-lesioned rats: inhibition of responses by hyperprolactinemia and evidence that testosterone and estradiol modulate gonadotropin secretion at postreceptor sites.
    Pieper DR; Gala RR; Schiff MA; Regiani SR; Marshall JC
    Endocrinology; 1984 Sep; 115(3):1190-6. PubMed ID: 6086288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basal follicle-stimulating hormone and peak gonadotropin levels after gonadotropin-releasing hormone infusion show high diagnostic accuracy in boys with suspicion of hypogonadotropic hypogonadism.
    Grinspon RP; Ropelato MG; Gottlieb S; Keselman A; Martínez A; Ballerini MG; Domené HM; Rey RA
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2811-8. PubMed ID: 20371659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of other than prolactin hormones on bone mineral density in women with hyperprolactinaemia of various origins.
    Bolanowski M; Zadrozna-Sliwka B; Jawiarczyk A; Syrycka J
    Gynecol Endocrinol; 2010 Aug; 26(8):623-7. PubMed ID: 20218822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catecholamines and pituitary function. I. Effects of catecholamine synthesis inhibition and subsequent catecholamine infusion on gonadotropin and prolactin serum levels in normal cycling women and in women with hyperprolactinemic amenorrhea.
    Nicoletti I; Filipponi P; Sfrappini M; Fedeli L; Petrelli S; Gregorini G; Santeusanio F; Brunetti P
    Horm Res; 1984; 19(3):158-70. PubMed ID: 6425187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of pituitary gonadotropin secretion by 4-aminopyrazolo(3,4-d) pyrimidine.
    Blank MS; Loumaye E; Sgoutas DS; Catt KJ; Dufau ML
    Endocrinology; 1983 Jun; 112(6):1973-9. PubMed ID: 6406206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Both hyper- and hypogonadotropic hypogonadism occur transiently in acute illness: bio- and immunoactive gonadotropins.
    Spratt DI; Bigos ST; Beitins I; Cox P; Longcope C; Orav J
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1562-70. PubMed ID: 1464665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ghrelin upon gonadotropin-releasing hormone and gonadotropin secretion in adult female rats: in vivo and in vitro studies.
    Fernández-Fernández R; Tena-Sempere M; Navarro VM; Barreiro ML; Castellano JM; Aguilar E; Pinilla L
    Neuroendocrinology; 2005; 82(5-6):245-55. PubMed ID: 16721030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone mineral density and bone turnover in hyperprolactinaemia of various origins.
    Zadrozna-Sliwka B; Bolanowski M; Kałuzny M; Syrycka J
    Endokrynol Pol; 2007; 58(2):116-22. PubMed ID: 17578827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
    Tresguerres JA; Esquifino AI
    Acta Physiol Lat Am; 1983; 33(3):257-74. PubMed ID: 6424409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.